976 related articles for article (PubMed ID: 18549372)
1. Examining the utility of in-clinic "rescue" therapy for acute migraine.
Morey V; Rothrock JF
Headache; 2008 Jun; 48(6):939-43. PubMed ID: 18549372
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
3. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
Landy SH
Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
[TBL] [Abstract][Full Text] [Related]
4. The impact of intensive patient education on clinical outcome in a clinic-based migraine population.
Rothrock JF; Parada VA; Sims C; Key K; Walters NS; Zweifler RM
Headache; 2006 May; 46(5):726-31. PubMed ID: 16643574
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
[TBL] [Abstract][Full Text] [Related]
6. Duration of migraine is a predictor for response to botulinum toxin type A.
Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
[TBL] [Abstract][Full Text] [Related]
7. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
[TBL] [Abstract][Full Text] [Related]
8. A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines.
Friedman BW; Hochberg M; Esses D; Bijur PE; Corbo J; Paternoster J; Solorzano C; Toosi B; Lipton RB; Gallagher EJ
Headache; 2006 Jun; 46(6):934-41. PubMed ID: 16732839
[TBL] [Abstract][Full Text] [Related]
9. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
Vicente-Herrero T; Burke TA; Laínez MJ
Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
[TBL] [Abstract][Full Text] [Related]
10. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial.
Tanen DA; Miller S; French T; Riffenburgh RH
Ann Emerg Med; 2003 Jun; 41(6):847-53. PubMed ID: 12764341
[TBL] [Abstract][Full Text] [Related]
11. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
12. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
14. Borderline personality disorder and migraine.
Rothrock J; Lopez I; Zweilfer R; Andress-Rothrock D; Drinkard R; Walters N
Headache; 2007 Jan; 47(1):22-6. PubMed ID: 17355490
[TBL] [Abstract][Full Text] [Related]
15. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
16. Acute migraine treatment: patterns of use and satisfaction in a clinical population.
Malik SN; Hopkins M; Young WB; Silberstein SD
Headache; 2006 May; 46(5):773-80. PubMed ID: 16643580
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of nonnarcotic protocol for the treatment of acute exacerbations of chronic nonmalignant pain.
Svenson JE; Meyer TD
Am J Emerg Med; 2007 May; 25(4):445-9. PubMed ID: 17499665
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a group outpatient visit model for chronically ill older health maintenance organization members: a 2-year randomized trial of the cooperative health care clinic.
Scott JC; Conner DA; Venohr I; Gade G; McKenzie M; Kramer AM; Bryant L; Beck A
J Am Geriatr Soc; 2004 Sep; 52(9):1463-70. PubMed ID: 15341547
[TBL] [Abstract][Full Text] [Related]
19. Characterization and prediction of emergency department use in chronic daily headache patients.
Freitag FG; Kozma CM; Slaton T; Osterhaus JT; Barron R
Headache; 2005; 45(7):891-8. PubMed ID: 15985106
[TBL] [Abstract][Full Text] [Related]
20. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
